Financials • Specialty Insurers
$2.23 ▲ +0.13
(+6.19%)
MKT CAP: $22.5M • VOL: 40.4K
52W L $1 52W H $4
ROARABLE / RQD
C+ • 68/100
PIOTROSKI
7 / 9
HUIZ // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $226.3M | $171.1M | $168.4M |
| YoY Revenue Growth % | +32.2% | +1.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $952.0K | -$2.9M | $7.2M |
| Operating Margin % | 0.4% | -1.7% | 4.3% |
| Net Income (GAAP) | $578.0K | -$89.0K | $9.9M |
| EBITDA (Normalized) | $1.9M | -$2.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.6M | -$2.6M | $19.3M |
| Capital Expenditures (CapEx) | $1.2M | $587.0K | — |
| Free Cash Flow (FCF) | $1.4M | -$3.2M | $19.3M |
| FCF Margin % | 0.6% | -1.9% | 11.5% |
| Return on Invested Capital (ROIC %) | 3.1% | -9.4% | — |
| Cash & Short-Term Equivalents | $35.9M | $31.9M | — |
| Total Debt (Short + Long Term) | $1.0M | — | — |
| Total Stockholders' Equity | $58.8M | $56.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HUIZ.